SABBY MANAGEMENT, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 30 filers reported holding TENAX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$19,000
-68.9%
32,842
-23.9%
0.01%
-52.9%
Q4 2019$61,000
-53.4%
43,164
-60.2%
0.02%
-41.4%
Q4 2018$131,000108,4270.03%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 108,427$131,0000.03%
FAS Wealth Partners, Inc. 58,576$71,0000.02%
ARMISTICE CAPITAL, LLC 84,590$102,0000.01%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
BARCLAYS PLC 100$00.00%
WELLS FARGO & COMPANY/MN 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 7,915$10,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders